» Articles » PMID: 3904410

Comparison of Clinician Ratings to Self Reports of Withdrawal During Clonidine Detoxification of Opiate Addicts

Overview
Publisher Informa Healthcare
Specialty Psychiatry
Date 1985 Jan 1
PMID 3904410
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Opiate withdrawal symptom ratings by trained clinicians were compared to self-reports of withdrawal discomfort during an outpatient, blinded, randomized clinical trial of clonidine detoxification for methadone maintained subjects. The randomized comparison group of subjects were detoxified using a slow tapering of methadone over 1 month. For all 39 subjects in this study the observer and self-ratings were substantially correlated (r = .75), but moderate levels of disagreement also occurred and the observer ratings were often lower. The difference in actual withdrawal scores and amount of shared variance between the observer and self-ratings were used as indices of disagreement for each individual subject. We found that detoxification failures had significantly less interrater agreement than the successes and that subjects who reported more distress than the observers noted were more likely to fail at detoxification. Subjects being detoxified using clonidine were more likely to fail at detoxification. Subjects being detoxified using clonidine were more likely to demonstrate this association between failure and disagreement on self versus observed withdrawal than were the methadone group. We concluded that self-reports are as important as observer ratings in assessing treatment efficacy and in the clinical use of clonidine for outpatient detoxification.

Citing Articles

Feasibility and Preliminary Efficacy of Isradipine During Outpatient Buprenorphine Stabilization and Detoxification: A Pilot Randomized, Placebo-Controlled Trial.

Kumar N, Mancino M, Thostenson J, McGaugh J, Oliveto A Subst Abuse. 2020; 14:1178221820970926.

PMID: 33281447 PMC: 7686602. DOI: 10.1177/1178221820970926.


Defining and Predicting Opioid and Cocaine Treatment Response.

Gardner R, Epstein D, Preston K, Phillips K Subst Use Misuse. 2019; 54(13):2134-2143.

PMID: 31315479 PMC: 8278306. DOI: 10.1080/10826084.2019.1638405.


Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes.

Dunn K, Weerts E, Huhn A, Schroeder J, Tompkins D, Bigelow G Addict Biol. 2018; 25(1):e12680.

PMID: 30295400 PMC: 6546557. DOI: 10.1111/adb.12680.


Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.

Dunn K, Tompkins D, Bigelow G, Strain E JAMA Psychiatry. 2017; 74(9):885-893.

PMID: 28700791 PMC: 5710234. DOI: 10.1001/jamapsychiatry.2017.1838.


Carvedilol does not reduce cocaine use in methadone-maintained cocaine users.

Sofuoglu M, Poling J, Babuscio T, Gonsai K, Severino K, Nich C J Subst Abuse Treat. 2016; 73:63-69.

PMID: 28017186 PMC: 5193370. DOI: 10.1016/j.jsat.2016.11.005.